TORONTO, Nov. 12, 2015 /CNW/ - The law firm Siskinds LLP has launched a
class action regarding Zofran.
Zofran is approved to treat nausea and vomiting in patients following
chemotherapy, radiation or surgery. However, Zofran has been prescribed
off-label to treat morning sickness in expectant mothers. Some studies
have noted an association between Zofran use in the first trimester of
pregnancy and birth defects such as congenital cardiac (heart)
malformations and oral clefts (cleft lip and/or cleft palate).
In commencing this class action, Siskinds seeks to recover compensation
for persons in Canada who experienced these conditions as a result of
their mothers being prescribed Zofran. The Statement of Claim alleges
that the defendant failed to adequately warn expectant mothers and
physicians that use of Zofran during the first trimester of pregnancy
increases the risk of serious birth defects.
Jill McCartney, a lawyer with Siskinds LLP, states: "As a matter of
safety, expectant mothers and their health care providers need to be
informed of the risks associated with using a particular pharmaceutical
product. This is particularly true during the first trimester of
pregnancy, when the baby is developing his or her organs."
Canadians who believe they might be affected by this class action are
encouraged to visit www.classaction.ca/zofran, email email@example.com or call 1-800-461-6166 ext. 2341 for English enquiries or ext. 2409 for
About Siskinds LLP
Siskinds LLP is a full-service law firm with offices in Toronto and
London, and affiliate offices in Montreal and Quebec City. Siskinds LLP
is Canada's leading class action law firm.
SOURCE Siskinds LLP
For further information:
Jill S. McCartney or Linda J. Visser, Siskinds LLP, 100 Lombard Street, Suite 302, Toronto, ON M5C 1M3, Tel: (416) 362-8334, Email: firstname.lastname@example.org.
Follow us on www.twitter.com/siskindsllp